L. Wexler

M. Ladanyi, W. Travis, C. Lau, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.

S. Larson, E. Calleja, A. Huvos, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lymphocyte depletion during treatment with intensive chemotherapy for cancer.

A. Shad, I. Magrath, C. Mackall, 1994, Blood.

Prolonged CD 4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults

C. Mackall, E. Read, L. Wexler, 2022 .

Late Toxicities of Intensity Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma

C. Sklar, S. Wolden, L. Wexler, 2015 .

Effects of Therapy on Dentofacial Development in Long-Term Survivors of Head and Neck Rhabdomyosarcoma: The Memorial Sloan-Kettering Cancer Center Experience

D. Kraus, C. Sklar, C. Estilo, 2003, Journal of pediatric hematology/oncology.

Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.

S. Wolden, L. Wexler, D. Casey, 2019, International journal of radiation oncology, biology, physics.

A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.

C. Antonescu, C. Estilo, S. Wolden, 2016, Oral oncology.

Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma

Narasimhan P. Agaram, Narasimhan P Agaram, C. Antonescu, 2016, The American journal of surgical pathology.

Long‐term survival after central nervous system relapse in a patient with osteosarcoma

T. Delaney, L. Wexler, M. Horowitz, 1993, Cancer.

Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma.

A. Huvos, M. LaQuaglia, L. Wexler, 2006, Journal of pediatric surgery.

Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors

A. Angiolillo, A. Levy, L. Wexler, 2009, Cancer.

When treatment does not work: failure to understand failure.

L. Wexler, 2018, The Lancet. Oncology.

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

J. Healey, M. LaQuaglia, L. Wexler, 2011, Cancer.

A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition

K. Offit, A. Kentsis, M. Walsh, 2017, Biomarker Research.

Ifosfamide dose‐intensification for patients with metastatic Ewing sarcoma

C. Pratilas, E. Riedel, L. Wexler, 2015, Pediatric blood & cancer.

Late Toxicities of Intensity‐Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma

C. Sklar, S. Wolden, L. Wexler, 2016, Pediatric Blood & Cancer.

Rhabdomyosarcoma and Other Soft-Tissue Sarcomas

L. Wexler, C. F. Levy, 2016 .

Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmation.

M. Ladanyi, L. Wexler, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy.

S. Steinberg, P. Pizzo, L. Wexler, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults.

W. Gerald, M. LaQuaglia, L. Wexler, 2006, Journal of pediatric surgery.

for cancer Lymphocyte depletion during treatment with intensive chemotherapy

C. Mackall, L. Wexler, T. Fleisher, 2011 .

Insulin-like growth factors and cytokines in pediatric cancer

L. Helman, L. Wexler, 1997 .

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors

N. Shukla, S. Roberts, J. G. Glade Bender, 2019, Front. Oncol..

A prospective evaluation of ifosfamide‐related nephrotoxicity in children and young adults

S. Izraeli, F. Balis, L. Wexler, 1995, Cancer.

PET for Staging in Rhabdomyosarcoma: An Evaluation of PET as an Adjunct to Current Staging Tools

H. Schöder, S. Wolden, L. Wexler, 2007, Journal of pediatric hematology/oncology.

Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.

B. Widemann, C. Mackall, K. Baird, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interferon-γ–Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo

G. Pinkus, G. Reid, S. Grupp, 2009, Clinical Cancer Research.

The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms

C. Antonescu, S. Singer, W. Tap, 2022, Modern Pathology.

Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy.

J. Teruya-Feldstein, L. Wexler, M. L. La Quaglia, 2004, Journal of pediatric hematology/oncology.

Metastatic Rhabdomyosarcoma: Still Room for Improvement.

L. Wexler, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan for Pediatric Solid Tumors: The Memorial Sloan-Kettering Experience

W. Gerald, E. Calleja, A. Huvos, 2002, Journal of pediatric hematology/oncology.

Increased risk of neuroectodermal tumors and stomach cancer in relatives of patients with Ewing's sarcoma family of tumors.

M. Tucker, A. Goldstein, L. Wexler, 1994, Journal of the National Cancer Institute.

Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma

Maristela L Onozato, A. Iafrate, M. Suvà, 2022, Nature Cancer.

Combined modality treatment of Ewing's sarcoma of the maxilla

A. Kacker, L. Close, L. Wexler, 2003, Head & neck.

Intensity‐modulated radiation therapy with dose‐painting for pediatric sarcomas with pulmonary metastases

L. Happersett, S. Wolden, L. Wexler, 2013, Pediatric blood & cancer.

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma

R. Samstein, S. Wolden, K. Pitter, 2019, Clinical Cancer Research.

Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors

D. Kraus, M. LaQuaglia, S. Wolden, 2008, Pediatric blood & cancer.

The challenging role of radiation therapy for very young children with rhabdomyosarcoma.

J. Healey, S. Wolden, L. Wexler, 2006, International journal of radiation oncology, biology, physics.

Loss of antibody titers and effectiveness of revaccination in post‐chemotherapy pediatric sarcoma patients

L. Wexler, R. Gorlick, P. Meyers, 2007, Pediatric blood & cancer.

Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study

C. Antonescu, S. Singer, W. Tap, 2022, Modern Pathology.

Experience with retroperitoneoscopy in pediatric surgical oncology

M. LaQuaglia, L. Wexler, Y. Sonoda, 2011, Surgical Endoscopy.

Pediatric nonrhabdomyosarcoma soft tissue sarcomas: progress on clinical and biologic fronts.

J. Garvin, L. Wexler, 1997, The Journal of pediatrics.

Lymphocyte depletion during treatment with intensive chemotherapy

A. Shad, I. Magrath, L. Wexler, 2002 .

Parameningeal rhabdomyosarcoma: outcomes and opportunities.

S. Wolden, L. Wexler, P. Meyers, 2013, International journal of radiation oncology, biology, physics.

Long-term effect of chemotherapy–intensity-modulated radiation therapy (chemo-IMRT) on dentofacial development in head and neck rhabdomyosarcoma patients

C. Antonescu, C. Estilo, S. Wolden, 2016, Pediatric hematology and oncology.

Sarcomas of the hand and foot: analysis of local control and functional result with combined modality therapy in extremity preservation.

D. Venzon, T. Delaney, P. Johnstone, 1994, International journal of radiation oncology, biology, physics.

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

C. Iacobuzio-Donahue, E. Papaemmanuil, G. Gundem, 2023, bioRxiv.

When silence is not golden: Engaging adolescents and young adults in discussions around end‐of‐life care choices

L. Wexler, L. Wiener, M. Pao, 2013, Pediatric blood & cancer.

Nevoid basal cell carcinoma syndrome with medulloblastoma in an African-American boy: a rare case illustrating gene-environment interaction.

A. Goldstein, J. DiGiovanna, L. Wexler, 1997, American journal of medical genetics.

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

D. Fairclough, T. Delaney, C. Pratt, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

J. Wolchok, C. Rodríguez-Galindo, M. Lodish, 2015, Clinical Cancer Research.

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Amber L. Simpson, V. Pascual, C. Rudin, 2020, Cell.

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

M. Hidalgo, H. Pass, R. Maki, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype

Narasimhan P. Agaram, C. Antonescu, B. Dickson, 2019, The American journal of surgical pathology.

Long‐term results of three‐dimensional conformal radiation therapy for patients with rhabdomyosarcoma

D. Kraus, M. LaQuaglia, S. Wolden, 2003, Cancer.

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

P. Meltzer, M. Ladanyi, E. Kleinerman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Gastrointestinal Stromal Tumors in Children and Young Adults: A Clinicopathologic, Molecular, and Genomic Study of 15 Cases and Review of the Literature

N. Socci, C. Antonescu, R. Maki, 2005, Journal of pediatric hematology/oncology.

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations

N. Socci, L. Qin, A. Viale, 2014, Nature Genetics.

EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.

P. Sorensen, M. Ladanyi, J. Wunder, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Narasimhan P. Agaram, N. Socci, N. Schultz, 2021, Nature Communications.

Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart

Narasimhan P. Agaram, C. Antonescu, P. Chi, 2022, Genes, chromosomes & cancer.

Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.

W. Shi, S. Singer, S. Wolden, 2013, International journal of radiation oncology, biology, physics.

A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases

Narasimhan P. Agaram, C. Antonescu, R. Alaggio, 2015, The American journal of surgical pathology.

Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions.

M. Ladanyi, R. Bhargava, D. Roulston, 2007, The Journal of molecular diagnostics : JMD.

Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.

J. Healey, P. Boland, M. LaQuaglia, 2006, International journal of radiation oncology, biology, physics.

Neural differentiation and prognosis in peripheral primitive neuroectodermal tumor.

W. Meyer, M. Tsokos, D. Parham, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-derived xenografts for individualized care in advanced sarcoma

David Sidransky, Robert Maki, R. Maki, 2014, Cancer.

Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior.

S. Steinberg, C. Tzen, W. Meyer, 1999, Human pathology.

Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience

L. Wexler, P. Meyers, A. Price, 2009, Pediatric blood & cancer.

Insulin‐like growth factor type 1 (IGF–1) and IGF binding protein–3 in patients with Ewing sarcoma family of tumors

S. Steinberg, J. Toretsky, L. Helman, 2001, Cancer.

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

S. Steinberg, T. Delaney, F. Balis, 1996, Cancer.

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

N. Schultz, M. Ladanyi, M. Berger, 2021, Nature Cancer.

Undifferentiated Round Cell Sarcoma with BCOR Internal Tandem Duplications (ITD) or YWHAE fusions: A Clinicopathologic and Molecular Study

C. Antonescu, C. Fletcher, A. Ferrari, 2020, Modern Pathology.

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

C. Iacobuzio-Donahue, E. Papaemmanuil, G. Gundem, 2023, bioRxiv.

NTRK3 Overexpression in Undifferentiated Sarcomas with YWHAE and BCOR Genetic Alterations

C. Antonescu, P. Argani, B. Dickson, 2020, Modern Pathology.

BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas

C. Antonescu, P. Argani, B. Dickson, 2017, The American journal of surgical pathology.

Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis

Narasimhan P. Agaram, C. Antonescu, M. LaQuaglia, 2014, Genes, chromosomes & cancer.

Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma

C. Antonescu, B. Dickson, C. Fletcher, 2017, The American journal of surgical pathology.

Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.

C. Thiele, U. Kontny, C. Mackall, 2003, Cancer research.

Insights into pediatric rhabdomyosarcoma research: Challenges and goals

S. Tapscott, J. Khan, C. Antonescu, 2019, Pediatric blood & cancer.

Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group

P. Adamson, F. Balis, B. Widemann, 2010, Clinical Cancer Research.

Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.

J. Mechalakos, J. Disa, M. Lacouture, 2020, JAMA dermatology.

Rhabdomyosarcoma: current challenges and their implications for developing therapies.

J. Khan, R. Pal, C. Keller, 2014, Cold Spring Harbor perspectives in medicine.

Developing Therapies Rhabdomyosarcoma : Current Challenges and Their Implications for

J. Khan, R. Pal, B. Stillman, 2014 .

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

S. Lipshultz, J. Healey, M. Devidas, 2016, Pediatric blood & cancer.

Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.

A. Huvos, J. Healey, C. Laverdière, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: The national cancer institute experience

P. Nathan, L. Helman, C. Mackall, 2005, Pediatric blood & cancer.

Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.

D. Kraus, E. Lis, M. LaQuaglia, 2004, International journal of radiation oncology, biology, physics.

Long-Term E vent-Free S urvival A fter I ntensive C hemotherapy for E wing's F amily o f T umors i n C hildren a nd Y oung A dults

A. Huvos, J. Healey, C. Laverdière, 2003 .

Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies.

S. Steinberg, M. Horowitz, H. Pass, 1998, The Annals of thoracic surgery.

Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors.

S. Steinberg, M. Horowitz, H. Pass, 1995, The Annals of thoracic surgery.

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.

S. Steinberg, D. Longo, T. Triche, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.

D. Dimitrov, I. Magrath, C. Mackall, 1997, Blood.

Experiences of cancer in children and adolescents.

T. Fears, M. Tucker, L. Wexler, 1996, Cancer nursing.

20-year experience with intraoperative high-dose-rate brachytherapy for pediatric sarcoma: outcomes, toxicity, and practice recommendations.

Suzanne L Wolden, Michael R Folkert, M. Zelefsky, 2014, International journal of radiation oncology, biology, physics.

Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor

M. LaQuaglia, S. Wolden, L. Wexler, 2015, Sarcoma.

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

P. Agius, Wei Yang, T. Chan, 2019, Nature Network Boston.

Central nervous system relapse of rhabdomyosarcoma

S. Wolden, L. Wexler, K. Kramer, 2018, Pediatric blood & cancer.

Malignant schwannoma with melanocytic and neuroepithelial differentiation in an infant with congenital giant melanocytic nevus: a complex neurocristopathy.

L. Medeiros, M. Roth, M. Tsokos, 1993, Human pathology.

Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

M. Ladanyi, E. Papaemmanuil, G. Gundem, 2021, Molecular Cancer Research.

MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification

Narasimhan P. Agaram, M. Ladanyi, C. Antonescu, 2018, Modern Pathology.

Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults.

C. Mackall, E. Read, L. Wexler, 2000, Blood.

Patterns of failure for rhabdomyosarcoma of the perineal and perianal region.

M. LaQuaglia, S. Wolden, L. Wexler, 2014, International journal of radiation oncology, biology, physics.

Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma.

L. Happersett, K. Dharmarajan, S. Wolden, 2012, International journal of radiation oncology, biology, physics.

The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue

L. Wexler, R. Gorlick, P. Meyers, 2008, Pediatric blood & cancer.

Methotrexate levels and outcome in osteosarcoma

W. Shi, A. Huvos, J. Healey, 2005, Pediatric blood & cancer.

Orbital Exenteration and Brachytherapy for the Treatment of Pediatric, Fusion-positive, Recurrent Rhabdomyosarcoma

S. Wolden, L. Wexler, D. Abramson, 2022, Plastic and reconstructive surgery. Global open.

Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.

H. Schoder, K. Dharmarajan, S. Wolden, 2012, International journal of radiation oncology, biology, physics.

Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive sarcomas.

A. Viale, M. Ladanyi, M. Berger, 2017, JCO precision oncology.

Clinical and molecular heterogeneity of head and neck spindle cell and sclerosing rhabdomyosarcoma.

C. Antonescu, C. Estilo, L. Wexler, 2016, Oral oncology.

Late Effects of Therapy in Survivors of Ewing's Sarcoma Family Tumors

T. Fears, M. Tucker, L. Wexler, 1997, Journal of pediatric hematology/oncology.

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors

J. Huse, J. Kolesar, D. Lyden, 2017, Pediatric blood & cancer.

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group

S. Lipshultz, M. Bernstein, K. Janeway, 2019, Cardio-Oncology.

Pediatric rhabdomyosarcoma with bone marrow metastasis

L. Wexler, Kayleen A. Bailey, Kayleen A Bailey, 2020, Pediatric blood & cancer.

A single‐center experience with undifferentiated embryonal sarcoma of the liver

S. Ambati, L. Wexler, P. Meyers, 2016, Pediatric blood & cancer.

Morbidity and mortality after treatment of Ewing sarcoma: A single‐institution experience

C. Moskowitz, K. Oeffinger, S. Wolden, 2017, Pediatric blood & cancer.

Analysis of serum insulin growth factor‐1 concentrations in localized osteosarcoma: A children's oncology group study

J. Toretsky, M. Bernstein, A. Goorin, 2014, Pediatric blood & cancer.

Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma

S. Wolden, L. Wexler, P. Meyers, 2015, Pediatric blood & cancer.

Jaw in a Day: State of the Art in Maxillary Reconstruction

D. Staffenberg, J. Levine, L. Wexler, 2016, The Journal of craniofacial surgery.

Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical hysterectomy.

Kay J. Park, S. Lewin, L. Wexler, 2009, Journal of Pediatric Surgery.

Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA

B. Crompton, J. Nemunaitis, L. Wexler, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche.

Amber J. Giles, R. Kaplan, D. Lyden, 2016, Cancer research.

A bi-shRNAfurin and GMCSF engineered autologous tumor cell immunotherapy vs. gemcitabine + docetaxel for Ewing sarcoma and with cryoablation in Ewing family tumors.

K. Neville, N. Senzer, J. Nemunaitis, 2017 .

Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma.

M. Berger, A. Kentsis, N. Shukla, 2017, Journal of pediatric hematology/oncology.

Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations

Narasimhan P. Agaram, C. Antonescu, W. Tap, 2021, Genes, chromosomes & cancer.

Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma

M. LaQuaglia, S. Wolden, L. Wexler, 2014, Pediatric blood & cancer.

Paratesticular rhabdomyosarcoma: Importance of initial therapy.

S. Wolden, L. Wexler, A. Price, 2017, Journal of pediatric surgery.

Concurrent radiation with irinotecan and carboplatin in intermediate‐ and high‐risk rhabdomyosarcoma: A report on toxicity and efficacy from a prospective pilot phase II study

Suzanne L Wolden, K. Dharmarajan, S. Wolden, 2013, Pediatric blood & cancer.

The role of neoadjuvant denosumab in the treatment of aneurysmal bone cysts: a case series and review of the literature.

M. Bilsky, L. Wexler, O. Barzilai, 2022, Journal of Neurosurgery: Pediatrics.

Treatment of osteosarcoma at first recurrence after contemporary therapy

A. Huvos, J. Healey, M. LaQuaglia, 2005, Cancer.

P9754 therapeutic intensification in non-metastatic osteosarcoma: A COG trial

M. Devidas, M. Bernstein, A. Goorin, 2004 .

P9754 therapeutic intensification in non-metastatic osteosarcoma: A COG trial.

M. Devidas, M. Bernstein, A. Goorin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies

W. Gerald, H. Thaler, E. Lis, 2007, Pediatric blood & cancer.

Vancomycin‐resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection

E. Riedel, L. Wexler, T. Small, 2009, Pediatric Blood & Cancer.

Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.

H. Schöder, J. Fox, D. Kuk, 2015, AJR. American journal of roentgenology.

The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES).

F. D. Cruz, S. Ambati, L. Wexler, 2018 .

Exenteration and Custom Implant Brachytherapy as a Treatment for Recurrent Primary Extraskeletal Orbital Ewing Sarcoma.

M. Klufas, S. Wolden, L. Wexler, 2015, Ophthalmic plastic and reconstructive surgery.

The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS).

S. Lipshultz, M. Bernstein, K. Janeway, 2012 .

Detection of (11;22)(q24;q12) translocation-bearing cells in peripheral blood progenitor cells of patients with Ewing's sarcoma family of tumors.

L. Neckers, J. Toretsky, L. Wexler, 1995, Journal of the National Cancer Institute.

Whole-Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases: Single-Institution Prospective Clinical Trial

S. Berry, L. Wexler, D. Casey, 2023, Applied Radiation Oncology.

Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction

Thomas J. Fuchs, Narasimhan P. Agaram, M. Hameed, 2022, The American journal of pathology.

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

S. Steinberg, A. Shad, I. Magrath, 1995, The New England journal of medicine.

Second cancer risk in childhood cancer survivors treated with intensity‐modulated radiation therapy (IMRT)

C. Sklar, C. Moskowitz, S. Wolden, 2015, Pediatric blood & cancer.

A pilot trial of irinotecan, temozolomide and bevacizumab (ITB) for treatment of newly diagnosed patients with desmoplastic small round cell tumor (DSRCT).

E. Riedel, G. Ulaner, S. Ambati, 2017 .

A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition

K. Offit, A. Kentsis, M. Walsh, 2017, Biomarker Research.

Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.

C. Antonescu, S. Wolden, L. Wexler, 2023, JCO precision oncology.

Positron Emission Tomography (PET) Response to Initial Chemotherapy and Radiation Therapy (RT) Predicts Local Control in Rhabdomyosarcoma

H. Schöder, K. Dharmarajan, S. Wolden, 2011 .

Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience

L. Wexler, P. Meyers, A. Price, 2009, Pediatric blood & cancer.

Ameliorating anthracycline cardiotoxicity in children with cancer: clinical trials with dexrazoxane.

L. Wexler, 1998, Seminars in oncology.